Leaders in HEOR and global market access services

Successfully supporting the healthcare industry for over 20 years

We are DRG Abacus, a Decision Resources Group company formally known as Abacus International.

Our multi-disciplinary team offers best in class health economics and outcomes research (HEOR) and market access services to the world’s leading pharmaceutical and medical device companies. We balance scientific rigor with commercial awareness, differentiating ourselves from our competition through innovation, technical excellence, and design.

MARKET ACCESS ROADMAP

Early development

Pre-clinical

i
Early PHASE

Phase I

i

Phase II

i

Marketing support

Early PHASE

Phase III

i

Regulatory submissions & launch

i
Early PHASE

Local market access submissions

i

Real world effectiveness

Early PHASE

Phase IV Defending the market

i

EARLY DEVELOPMENT

EARLY PHASE

MARKETING SUPPORT

PRE LAUNCH / MARKET ACCESS
LAUNCH
POST LAUNCH

REAL WORLD
EFFECTIVENESS

Pre-clinical

  • Understand the commercial and clinical opportunities, and market dynamics
  • Prepare and plan for clinical development

Strategic

  • Commercial evaluation
  • Landscape assessments
  • Securing R&D investment

Implementation

  • Identify unmet need
  • Landscape assessments

Phase I

  • Commitment to clinical development
  • Understand the context, landscape, situation, and early market access strategy development

Strategic

  • Target product profiling
  • Early pricing and market access strategy development
  • Identification of key stakeholders
  • PR and publications planning

Implementation

  • Evidence review and GAP analysis
  • Stakeholder mapping
  • Competitor profiling
  • Early modelling

Phase II

  • Implementation of clinical development
  • Generate the evidence: clinical, HEOR, and RWE

Strategic

  • Go-No-Go decision to full development
  • Define value proposition
  • Develop payer evidence strategy
  • Outline global market access plan

Implementation

  • Early value dossier
  • PRO identification
  • Validation of clinical outcomes and endpoints
  • Economic modelling

Phase III

  • Significant investment and further commitment to clinical development
  • Ongoing evidence generation
  • Global and local implementation of the market access strategy

Strategic

  • Confirm the value story
  • Pricing research
  • Confirm P&MA strategy for key markets
  • Competitor profiling

Implementation

  • Evidence synthesis including SRs and NMAs
  • Database and RWE studies
  • Value message testing
  • Global economic modelling
  • Outcomes research

Regulatory submissions & launch

  • Ongoing evidence generation for local markets
  • Implementation of the market access strategy
  • Communication of the value

Strategic

  • Launch sequencing
  • Pricing model agreed
  • P&R dossier development
  • Communication strategy development
  • Internal market access capabilities

Implementation

  • Global value dossier development
  • Global and local evidence generation activities
  • Economic modelling
  • Publications support
  • Market access and HEOR training

Local market access submissions

  • Extensive local commercial and clinical preparation
  • Coordination of payer and HTA strategy and activity

Strategic

  • Country HTA and CER submission strategy
  • Development of managed entry agreements
  • Coverage with evidence development considerations

Implementation

  • Comprehensive HTA submission support
  • Local budget impact modelling
  • Stakeholder communication tools
  • Secondary research market access platform

Phase IV & Defending the Market

  • Longer term strategy
  • ROI secured
  • Value communications
  • Expanding and defending listing

Strategic

  • Defend value strategies
  • Identify growth opportunities
  • Line extensions
  • New indications
  • P&MA strategies
  • Respond to delisting and MTAs

Implementation

  • Ongoing evidence generation and synthesis (SR, NMA, RWE analysis and outcomes research)
  • Global value dossier updates
  • Economic modelling updates
  • Value communications
  • Secondary research market access platforms

To find out more about the market access roadmap service please get in touch

Products and Services

We provide integrated HEOR and market access services to global pharmaceutical product development organisations and medical device companies.

Our Products

Our Expertise

Our in-house team of strategists, health economists, researchers, medical writers, systematic reviewers, statisticians, designers, developers, and project managers allows you to achieve all aspects of your HEOR and market access goals, eliminating the need to commission several different agencies.

Our Expertise

Latest News, Events and Blogs

Stay up-to-date with our latest news, industry articles, blogs, press releases, events and announcements. Connect with us on Twitter and LinkedIn!

We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.

DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.

Our Company
© DRG Abacus 2017